Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Is Immunotherapy Appropriate Here?
2018 AONN Midyear
,
Video Library
,
Immunotherapy
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
Related Items
Applying CAR T-Cell Therapies to Solid Tumors: Overcoming Current Challenges
By
Chase Doyle
Articles
Web Exclusives
,
Immunotherapy
Evolving Immuno-Oncology Strategies in Renal-Cell Carcinoma
By
Wayne Kuznar
Articles
Web Exclusives
,
Immunotherapy
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
By
Chase Doyle
Articles
Web Exclusives
,
Immunotherapy
Identifying and Solving Top Challenges to Oncology Biomarker Testing
Video
PMO Interview with the Innovator Series: Volume 12
,
Video Library
Overcoming Challenges to Molecular Biomarker Testing
Video
PMO Interview with the Innovator Series: Volume 12
,
Video Library
Impact of Reimbursement for Biomarker Testing on Clinical Practice
Video
PMO Interview with the Innovator Series: Volume 12
,
Video Library
Navigating the CMS 14-Day Rule in Biomarker Testing
Video
PMO Interview with the Innovator Series: Volume 12
,
Video Library
Choosing Immunotherapy
Video
2018 AONN Midyear
,
Video Library
,
Immunotherapy
Changing the Conversation: Immunotherapy and Long-Term Survival
Video
2018 AONN Midyear
,
Video Library
,
Immunotherapy
The Evolving Field of Treatment Modalities
Video
2018 AONN Midyear
,
Video Library
,
Immunotherapy